ArticlePloS one2021

In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.

Andrea Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.